ZYDUS LIFESCIENCES
Back to Cashflow Statement
|
ZYDUS LIFESCIENCES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹3,228 Cr | ₹2,689 Cr | ₹2,105 Cr | ₹3,294 Cr | ₹2,932 Cr |
What is the latest Cash Flow from Operating Activities ratio of ZYDUS LIFESCIENCES ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2024 | ₹3,228 Cr |
Mar2023 | ₹2,689 Cr |
Mar2022 | ₹2,105 Cr |
Mar2021 | ₹3,294 Cr |
Mar2020 | ₹2,932 Cr |
How is Cash Flow from Operating Activities of ZYDUS LIFESCIENCES Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2024 | ₹3,228 Cr | 20.05 | |
Mar2023 | ₹2,689 Cr | 27.76 | |
Mar2022 | ₹2,105 Cr | -36.11 | |
Mar2021 | ₹3,294 Cr | 12.36 | |
Mar2020 | ₹2,932 Cr | - |
Compare Cash Flow from Operating Activities of peers of ZYDUS LIFESCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ZYDUS LIFESCIENCES | ₹83,655.5 Cr | -1.6% | -5.8% | -14.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹420,136.0 Cr | 6% | 4% | 9.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹149,680.0 Cr | 4.7% | 0.3% | 52.4% | Stock Analytics | |
CIPLA | ₹122,390.0 Cr | 7% | 3.7% | 7.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,159.0 Cr | 4.1% | 6.4% | 25% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,105.6 Cr | 6.3% | 5% | -4.7% | Stock Analytics |
ZYDUS LIFESCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ZYDUS LIFESCIENCES | -1.6% |
-5.8% |
-14.5% |
SENSEX | 5.8% |
6.1% |
4.7% |
You may also like the below Video Courses